Good morning, everyone, and how are you today? We have a busy agenda planned and so we are not wasting time: a delicious cup of stimulation is in hand and another is already being brewed. This is our version of the two-fisted drinker. Feel free to join us, of course, as you attack your own to-do list of meetings and deadlines. Meanwhile, here is the usual line-up of interesting items. Hope your day goes well and let us know if you hear something interesting.
Sanofi CEO Pledges 'Thoughtful' Job Cuts (Bloomberg News)
UK Health Authority Backs Down In Novartis Eye Drug Dispute (Reuters)
Lupin Plans To Acquire US Brands (Bloomberg News)
US Senate Attacks Distributors For Price Gouging (CNN)
Medivation Prostate Cancer Drug Gets FDA Priority Review (Reuters)
Genzyme Ordered To Pay $50M To Settle Patent Fight (Boston Business Journal)
Generic Plavix Hurts Bristol-Myers Earnings (Pharma Times)
Novartis Resumes Production Of Excedrin (Migraine.com)
Widespread Steroid Use Causes Concern (Reuters)
Roche Profit Falls On Costs To Close NJ Site (Bloomberg News)
Half Of Heart Patients Do Not Stick To Their Meds (Reuters)
EDITOR'S NOTE: Please check this post for updates during the day